51
Participants
Start Date
January 7, 2019
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
Levoketoconazole
Levoketoconazole up to 1200 mg daily
Semmelweis Egyetem II. Belgyógyászati Klinika, Budapest
Alexandovska University Hospital, Sofia
University Specialized Hospital for Active Treatment in Endocrinology, Sofia
Sveti Georgy University Hospital Clinic of Endocrinology and Metabolic Diseases, Plovdiv
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
University of Turin, Turin
General Hospital of Athens Evangelismos Department of Endocrinology and Diabete, Athens
APHM Hôpital de la Conception, Marseille
Hospital Universitario Ramón y Cajal, Madrid
Emory University, Atlanta
The Center for Diabetes and Endocrine Care, Fort Lauderdale
Bnai Zion Medical Center Endocrinology Institute, Haifa
Cleveland Clinic, Cleveland
Hospital Universidad De La Ribera, Alzira
Rabin Medical Center, Beilinson Campus, Petah Tikva
Hippokration General Hospital Endocrinology and Diabetes Department, Thessaloniki
Clinica Endocrinologia malattie del Metabolismo, Ancona
Washington University School of Medicine, St Louis
Via Sergio Pansini 5 Uni Naples FedericoII Dept of Molecular&Clinical Endocrinology&Oncology, Naples
University of New Mexico HSC - HSC Sponsored Projects Office, Albuquerque
Oregon Health & Science University, Portland
AOU Policlinico G. Martino Sezione di Endocrinologia, Messina
Institutul National de Endocrinologie C.I. Parhon, Cluj-Napoca
Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Cluj-Napoca
Spitalul Clinic Judetean Mures, Târgu Mureş
Tel Aviv-Sourasky Medical Center Institute Endocrinology Metabolism & Hypertension, Tel Aviv
Policlinico Universitario Sant'Andrea, Roma
Erasmus Medical Center, Rotterdam
Instytut Centrum Zdrowia Matki Polki, Lodz
Lead Sponsor
Cortendo AB
INDUSTRY